By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


DOV Pharmaceutical 

Continental Plaza
433 Hackensack Avenue
Hackensack  New Jersey  07601  U.S.A.
Phone: 201-968-0980 Fax:




Merck & Co.  Depression

Company News
Euthymics Bioscience, Inc. Closes $24 Million Series A Financing and Completes Acquisition of DOV Pharmaceutical 7/22/2010 6:32:38 AM
Euthymics Bioscience, Inc. and DOV Pharmaceutical Announce Merger Agreement 7/1/2010 7:09:04 AM
Euthymics Bioscience, Inc. Announces Letter of Intent for Acquisition of DOV Pharmaceutical 2/12/2010 11:00:10 AM
DOV Pharmaceutical Announces Successful Restructuring of Office Lease 3/4/2008 10:21:20 AM
DOV Pharmaceutical Announces Third Quarter Results 11/7/2007 2:23:08 PM
DOV Pharmaceutical to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 11/5/2007 12:10:21 PM
DOV Pharmaceutical DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study 9/25/2007 7:49:22 AM
DOV Pharmaceutical Begins Trading on OTC Bulletin Board 8/29/2007 8:28:00 AM
DOV Pharmaceutical Announces Successful Phase Ib Results for DOV 21,947 8/9/2007 11:01:25 AM
DOV Pharmaceutical Announces Second Quarter 2007 Results 8/9/2007 9:27:16 AM